Skip to main content
Livermore
Livermore
ZHEN

TRV GP IV, LLC

SEC CIK
0001688325
Latest filing
Aug 7, 2026

TNGX holding history

Tango Therapeutics, Inc. in every 13F filed by TRV GP IV, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TNGX overviewAll 13F holders of TNGXFull Q2 2026 holdings

Shares (Q2 2026)
6,374,574
Value
$120.2M
% of portfolio
47.4%
Quarters held
20
Since Q3 2021
Holdings of TNGX by TRV GP IV, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,374,574$120.2M47.4%00.0%UnchangedHolders
Q1 20266,374,574$133.4M50.0%−1,500,000−19.0%ReducedHolders
Q4 20257,874,574$69.8M27.3%−5,989,401−43.2%ReducedHolders
Q3 202513,863,975$116.5M42.5%−2,995,100−17.8%ReducedHolders
Q2 202516,859,075$86.3M52.9%00.0%UnchangedHolders
Q1 202516,859,075$23.1M24.9%00.0%UnchangedHolders
Q4 202416,859,075$52.1M65.0%00.0%UnchangedHolders
Q3 202416,859,075$129.8M80.1%−2,342,400−12.2%ReducedHolders
Q2 202419,201,475$164.7M81.5%00.0%UnchangedHolders
Q1 202419,201,475$152.5M73.9%−162,500−0.8%ReducedHolders
Q4 202319,363,975$191.7M77.9%00.0%UnchangedHolders
Q3 202319,363,975$218.0M82.1%00.0%UnchangedHolders
Q2 202319,363,975$64.3M58.1%00.0%UnchangedHolders
Q1 202319,363,975$76.5M54.7%00.0%UnchangedHolders
Q4 202219,363,975$140.4M59.7%00.0%UnchangedHolders
Q3 202219,363,975$70.1M41.0%00.0%UnchangedHolders
Q2 202219,363,975$87.7M57.7%00.0%UnchangedHolders
Q1 202219,363,975$146.8M53.8%00.0%UnchangedHolders
Q4 202119,363,975$211.8M60.9%00.0%UnchangedHolders
Q3 202119,363,975$250.4M56.8%+19,363,975NewHolders